Want to see ATXI full AI Analyst Report?
Avenue Therapeutics (ATXI) Financial Statements
Avenue Therapeutics Financial Overview
Avenue Therapeutics's market cap is currently $1.41M. The company's EPS TTM is $-0.85; its P/E ratio is -0.50; Avenue Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.40M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 1.40M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -3.29M | $ -11.28M | $ -14.54M | $ -8.04M | $ -3.74M |
| EBITDA | $ -3.29M | $ -11.70M | $ 4.05M | $ -2.44M | $ 7.00K |
| Net Income | $ -2.91M | $ -11.65M | $ -10.38M | $ -3.55M | $ -3.73M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.85M | $ 2.59M | $ 1.78M | $ 6.71M | $ 3.76M |
| Total Assets | $ 2.93M | $ 2.67M | $ 1.85M | $ 6.84M | $ 3.96M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -2.85M | $ -2.59M | $ -1.78M | $ -6.71M | $ -3.76M |
| Total Liabilities | $ 1.10M | $ 816.00K | $ 1.20M | $ 3.58M | $ 509.00K |
| Stockholders' Equity | $ 1.83M | $ 2.80M | $ 1.58M | $ 3.90M | $ 3.45M |
| Cash Flow | |||||
| Free Cash Flow | $ -1.83M | $ -9.03M | $ -12.45M | $ -7.60M | $ -3.75M |
| Operating Cash Flow | $ -1.83M | $ -9.03M | $ -9.45M | $ -7.60M | $ -3.75M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ -3.00M | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 2.09M | $ 9.84M | $ 7.53M | $ 10.54M | $ 4.38M |
Currency in USD